Recent Finacing
Recent Raise
bioAffinity Technologies develops a porphyrin-based CyPath platform for non-invasive early cancer diagnostics — an at-home sputum collection and lab-based automated flow-cytometric lung cancer test — and advances targeted therapeutics via OncoSelect
